(MAIN) Main Street Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US56035L1044
Stock: Private Equity, Debt Capital, Business Finance
Total Rating 33
Risk 63
Buy Signal -0.40
| Risk 5d forecast | |
|---|---|
| Volatility | 21.6% |
| Relative Tail Risk | 0.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.19 |
| Alpha | -9.05 |
| Character TTM | |
|---|---|
| Beta | 0.605 |
| Beta Downside | 0.869 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.97% |
| CAGR/Max DD | 1.11 |
EPS (Earnings per Share)
Revenue
Description: MAIN Main Street Capital March 05, 2026
Main Street Capital Corporation (MAIN) operates as a business development company (BDC), a type of investment company that invests in small and mid-sized companies. It also functions as a Small Business Investment Company (SBIC), a program designed to facilitate the flow of private capital to small businesses.
MAIN focuses on direct investments, providing private equity to lower middle market companies. This involves various financing structures such as recapitalizations, growth capital, and mezzanine debt, a hybrid of debt and equity financing. The firm engages in both control and non-control equity investments.
Additionally, MAIN supplies debt capital to middle market companies for purposes like strategic acquisitions and management buyouts. The firm offers diverse debt financing solutions, including private debt and private equity to its target markets. MAIN seeks partnerships with entrepreneurs and management teams, offering integrated financing options.
MAIN invests across a broad range of sectors, including air freight and logistics, auto components, healthcare, and software. Understanding the specific financial metrics and investment performance within these sectors can provide further insight. To delve deeper into MAINs financials and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Lower middle market investment performance drives revenue growth
- Interest rate fluctuations impact debt investment profitability
- Middle market company acquisition activity influences deal flow
- Regulatory changes for BDCs affect operational flexibility
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 493.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 7.91 > 1.0 |
| NWC/Revenue: 73.43% < 20% (prev 18.07%; Δ 55.36% < -1%) |
| CFO/TA 0.06 > 3% & CFO 354.5m > Net Income 493.4m |
| Net Debt (2.42b) to EBITDA (520.4m): 4.64 < 3 |
| Current Ratio: 449.8 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.8m) vs 12m ago 1.62% < -2% |
| Gross Margin: 86.91% > 18% (prev 0.83%; Δ 8608 % > 0.5%) |
| Asset Turnover: 13.56% > 50% (prev 14.15%; Δ -0.59% > 0%) |
| Interest Coverage Ratio: 5.22 > 6 (EBITDA TTM 520.4m / Interest Expense TTM 96.2m) |
Altman Z'' 1.75
| A: 0.09 (Total Current Assets 540.7m - Total Current Liabilities 1.20m) / Total Assets 5.71b |
| B: 0.09 (Retained Earnings 535.3m / Total Assets 5.71b) |
| C: 0.09 (EBIT TTM 501.7m / Avg Total Assets 5.42b) |
| D: 0.20 (Book Value of Equity 536.2m / Total Liabilities 2.72b) |
| Altman-Z'' Score: 1.75 = BBB |
Beneish M
| DSRI: 1.09 (Receivables 107.9m/98.1m, Revenue 734.8m/724.7m) |
| GMI: 0.95 (GM 86.91% / 82.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.01 (Revenue 734.8m / 724.7m) |
| TATA: 0.02 (NI 493.4m - CFO 354.5m) / TA 5.71b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of MAIN shares?
As of March 11, 2026, the stock is trading at USD 56.78 with a total of 432,661 shares traded.
Over the past week, the price has changed by -0.29%, over one month by -8.10%, over three months by -8.14% and over the past year by +5.84%.
Over the past week, the price has changed by -0.29%, over one month by -8.10%, over three months by -8.14% and over the past year by +5.84%.
Is MAIN a buy, sell or hold?
Main Street Capital has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold MAIN.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MAIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.8 | 12.4% |
| Analysts Target Price | 63.8 | 12.4% |
MAIN Fundamental Data Overview March 08, 2026
P/E Trailing = 9.4983
P/E Forward = 15.015
P/S = 9.0744
P/B = 1.7978
P/EG = 1.7605
Revenue TTM = 734.8m USD
EBIT TTM = 501.7m USD
EBITDA TTM = 520.4m USD
Long Term Debt = 2.46b USD (estimated: total debt 2.46b - short term 1.20m)
Short Term Debt = 1.20m USD (from shortTermDebt, last quarter)
Debt = 2.46b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.42b USD (from netDebt column, last quarter)
Enterprise Value = 7.56b USD (5.14b + Debt 2.46b - CCE 42.0m)
Interest Coverage Ratio = 5.22 (Ebit TTM 501.7m / Interest Expense TTM 96.2m)
EV/FCF = 21.31x (Enterprise Value 7.56b / FCF TTM 354.5m)
FCF Yield = 4.69% (FCF TTM 354.5m / Enterprise Value 7.56b)
FCF Margin = 48.24% (FCF TTM 354.5m / Revenue TTM 734.8m)
Net Margin = 67.15% (Net Income TTM 493.4m / Revenue TTM 734.8m)
Gross Margin = 86.91% ((Revenue TTM 734.8m - Cost of Revenue TTM 96.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 82.32%)
Tobins Q-Ratio = 1.32 (Enterprise Value 7.56b / Total Assets 5.71b)
Interest Expense / Debt = 1.32% (Interest Expense 32.5m / Debt 2.46b)
Taxrate = 3.98% (5.44m / 136.6m)
NOPAT = 481.7m (EBIT 501.7m * (1 - 3.98%))
Current Ratio = 449.8 (out of range, set to none) (Total Current Assets 540.7m / Total Current Liabilities 1.20m)
Debt / Equity = 0.82 (Debt 2.46b / totalStockholderEquity, last quarter 2.99b)
Debt / EBITDA = 4.64 (Net Debt 2.42b / EBITDA 520.4m)
Debt / FCF = 6.81 (Net Debt 2.42b / FCF TTM 354.5m)
Total Stockholder Equity = 2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.11% (Net Income 493.4m / Total Assets 5.71b)
RoE = 16.94% (Net Income TTM 493.4m / Total Stockholder Equity 2.91b)
RoCE = 9.34% (EBIT 501.7m / Capital Employed (Equity 2.91b + L.T.Debt 2.46b))
RoIC = 9.46% (NOPAT 481.7m / Invested Capital 5.09b)
WACC = 5.92% (E(5.14b)/V(7.60b) * Re(8.15%) + D(2.46b)/V(7.60b) * Rd(1.32%) * (1-Tc(0.04)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.15%
[DCF] Terminal Value 80.69% ; FCFF base≈354.5m ; Y1≈232.7m ; Y5≈106.2m
[DCF] Fair Price = 10.51 (EV 3.36b - Net Debt 2.42b = Equity 942.0m / Shares 89.6m; r=5.92% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 70.34 | EPS CAGR: 9.62% | SUE: 0.22 | # QB: 0
Revenue Correlation: 77.57 | Revenue CAGR: 21.59% | SUE: 1.51 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.02 | Chg7d=+0.021 | Chg30d=+0.024 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=+0.093 | Chg30d=+0.110 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+4.9%
EPS next Year (2027-12-31): EPS=4.08 | Chg7d=+0.134 | Chg30d=+0.129 | Revisions Net=+0 | Growth EPS=+0.5% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.4% (Discount Rate 8.2% - Earnings Yield 10.5%)
[Growth] Growth Spread = +5.1% (Analyst 2.7% - Implied -2.4%)
P/E Forward = 15.015
P/S = 9.0744
P/B = 1.7978
P/EG = 1.7605
Revenue TTM = 734.8m USD
EBIT TTM = 501.7m USD
EBITDA TTM = 520.4m USD
Long Term Debt = 2.46b USD (estimated: total debt 2.46b - short term 1.20m)
Short Term Debt = 1.20m USD (from shortTermDebt, last quarter)
Debt = 2.46b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.42b USD (from netDebt column, last quarter)
Enterprise Value = 7.56b USD (5.14b + Debt 2.46b - CCE 42.0m)
Interest Coverage Ratio = 5.22 (Ebit TTM 501.7m / Interest Expense TTM 96.2m)
EV/FCF = 21.31x (Enterprise Value 7.56b / FCF TTM 354.5m)
FCF Yield = 4.69% (FCF TTM 354.5m / Enterprise Value 7.56b)
FCF Margin = 48.24% (FCF TTM 354.5m / Revenue TTM 734.8m)
Net Margin = 67.15% (Net Income TTM 493.4m / Revenue TTM 734.8m)
Gross Margin = 86.91% ((Revenue TTM 734.8m - Cost of Revenue TTM 96.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 82.32%)
Tobins Q-Ratio = 1.32 (Enterprise Value 7.56b / Total Assets 5.71b)
Interest Expense / Debt = 1.32% (Interest Expense 32.5m / Debt 2.46b)
Taxrate = 3.98% (5.44m / 136.6m)
NOPAT = 481.7m (EBIT 501.7m * (1 - 3.98%))
Current Ratio = 449.8 (out of range, set to none) (Total Current Assets 540.7m / Total Current Liabilities 1.20m)
Debt / Equity = 0.82 (Debt 2.46b / totalStockholderEquity, last quarter 2.99b)
Debt / EBITDA = 4.64 (Net Debt 2.42b / EBITDA 520.4m)
Debt / FCF = 6.81 (Net Debt 2.42b / FCF TTM 354.5m)
Total Stockholder Equity = 2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.11% (Net Income 493.4m / Total Assets 5.71b)
RoE = 16.94% (Net Income TTM 493.4m / Total Stockholder Equity 2.91b)
RoCE = 9.34% (EBIT 501.7m / Capital Employed (Equity 2.91b + L.T.Debt 2.46b))
RoIC = 9.46% (NOPAT 481.7m / Invested Capital 5.09b)
WACC = 5.92% (E(5.14b)/V(7.60b) * Re(8.15%) + D(2.46b)/V(7.60b) * Rd(1.32%) * (1-Tc(0.04)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.15%
[DCF] Terminal Value 80.69% ; FCFF base≈354.5m ; Y1≈232.7m ; Y5≈106.2m
[DCF] Fair Price = 10.51 (EV 3.36b - Net Debt 2.42b = Equity 942.0m / Shares 89.6m; r=5.92% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 70.34 | EPS CAGR: 9.62% | SUE: 0.22 | # QB: 0
Revenue Correlation: 77.57 | Revenue CAGR: 21.59% | SUE: 1.51 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.02 | Chg7d=+0.021 | Chg30d=+0.024 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=+0.093 | Chg30d=+0.110 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+4.9%
EPS next Year (2027-12-31): EPS=4.08 | Chg7d=+0.134 | Chg30d=+0.129 | Revisions Net=+0 | Growth EPS=+0.5% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.4% (Discount Rate 8.2% - Earnings Yield 10.5%)
[Growth] Growth Spread = +5.1% (Analyst 2.7% - Implied -2.4%)